{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:13:41Z","timestamp":1788592421374,"version":"build-2803163510"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Platelet-rich plasma (PRP) is an innovative tool in regenerative medicine. It is defined as an autologous product obtained by density gradient centrifugation of blood, resulting in a platelet concentrate rich in growth factors. In gynecology, PRP has been used to treat vaginal atrophy, sexual dysfunction, and inflammatory conditions such as vulvar lichen sclerosus. PRP injection into the vulvo-vaginal area is a potential treatment for several conditions; however, treatment methods and applications vary widely across the published literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To provide an updated synthesis of current evidence on the administration of PRP to the vulva and vagina as a stand-alone technique in a non-surgical outpatient setting, and to identify its main clinical indications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of PubMed and Embase was conducted for studies published up to October 2024 using the terms \u201cplatelet rich plasma\u201d AND \u201cvaginal\u201d and \u201cplatelet rich plasma\u201d AND \u201cvulvar.\u201d Eligible studies included human case reports, prospective, and retrospective cohort studies, as well as randomized and non-randomized controlled trials, assessing PRP injections as a stand-alone technique in the vulvo-vaginal area. Extracted data included study design, patient characteristics, indications, PRP preparation and administration protocols, number of sessions, outcomes, and adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighteen studies met the inclusion criteria: two randomized controlled trials, 10 single-arm clinical trials, one retrospective cross-sectional study, and five case reports, comprising 480 patients (401 treated with PRP). The most frequent indication was vulvar lichen sclerosus (n\u2009=\u2009179), followed by sexual dysfunction (n\u2009=\u2009133) and vulvovaginal atrophy (n\u2009=\u200987). Protocols varied in preparation methods, injection techniques, and treatment schedules. Across studies, PRP injections were associated with improvements in symptoms, sexual function, and vaginal health, with few and mild adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence suggests that PRP injections in the vulvo-vaginal area may offer clinical benefits across several indications, with a favorable safety profile. However, the high variability in protocols, small sample sizes, and methodological limitations preclude definitive conclusions. Further high-quality randomized controlled trials are required to establish standardized protocols and confirm efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdaf307","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:59:40Z","timestamp":1760097580000},"source":"Crossref","is-referenced-by-count":3,"title":["Platelet-rich plasma in the management of vulvovaginal disorders: a systematic review"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5237-6993","authenticated-orcid":false,"given":"Antonella","family":"De Ponte","sequence":"first","affiliation":[{"name":"Gynecology, Obstetrics and Reproductive Medicine Department, Hospital Universitari Quir\u00f3n Dexeus, Dexeus Mujer , Barcelona 08028 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cabrera","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Santiago Dexeus Font, Dexeus Mujer , Barcelona 08028,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Sof\u00eda Berm\u00fadez","family":"Sparice","sequence":"additional","affiliation":[{"name":"Gynecology, Obstetrics and Reproductive Medicine Department, Hospital Universitari Quir\u00f3n Dexeus, Dexeus Mujer , Barcelona 08028 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Baulies","sequence":"additional","affiliation":[{"name":"Gynecology, Obstetrics and Reproductive Medicine Department, Hospital Universitari Quir\u00f3n Dexeus, Dexeus Mujer , Barcelona 08028 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6586-0111","authenticated-orcid":false,"given":"Ignacio","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Gynecology, Obstetrics and Reproductive Medicine Department, Hospital Universitari Quir\u00f3n Dexeus, Dexeus Mujer , Barcelona 08028 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"4","key":"2026010506140289700_ref1","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1073\/pnas.71.4.1207","article-title":"A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro","volume":"71","author":"Ross","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026010506140289700_ref2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1073\/pnas.68.2.271","article-title":"Calcium as a regulator of the proliferation of normal, but not of transformed, chicken fibroblasts in a plasma-containing medium","volume":"68","author":"Balk","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2026010506140289700_ref3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/s1079-2104(98)90029-4","article-title":"Platelet-rich plasma: growth factor enhancement for bone grafts","volume":"85","author":"Marx","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2026010506140289700_ref4","volume-title":"RegenPRP\u00ae: Standardized Platelet-Rich Plasma for Skin, Hair & Genitourinary Disorders","author":"Turzi","year":"2021"},{"key":"2026010506140289700_ref5","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1016\/j.biomaterials.2007.06.037","article-title":"The potential impact of the preparation rich in growth factors (PRGF) in different medical fields","volume":"28","author":"Anitua","year":"2007","journal-title":"Biomaterials."},{"key":"2026010506140289700_ref6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.joms.2003.12.003","article-title":"Platelet-rich plasma: evidence to support its use","volume":"62","author":"Marx","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"2026010506140289700_ref7","doi-asserted-by":"publisher","first-page":"e614","DOI":"10.4317\/medoral.16.e614","article-title":"Quantification of growth factors by using a new system for obtaining platelet-rich plasma","volume":"16","author":"Lorente-P\u00e9rez-Sierra","year":"2011","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2026010506140289700_ref8","volume-title":"EN 16844 A2: European Standard for Aesthetic Medicine in Non-Surgical Medical Treatments","author":"European Committee for Standardization (CEN)","year":"2019"},{"issue":"4","key":"2026010506140289700_ref9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0268-960x(89)90034-9","article-title":"Platelet-derived growth factors","volume":"3","author":"Miyazono","year":"1989","journal-title":"Blood Rev"},{"issue":"3","key":"2026010506140289700_ref10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.32098\/mltj.03.2013.05","article-title":"Augmenting tendon and ligament repair with platelet-rich plasma (PRP)","volume":"3","author":"Yuan","year":"2013","journal-title":"Muscles Ligaments Tendons J"},{"issue":"7","key":"2026010506140289700_ref11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","article-title":"Platelet-rich plasma: the PAW classification system","volume":"28","author":"DeLong","year":"2012","journal-title":"Arthroscopy."},{"issue":"6","key":"2026010506140289700_ref12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/aji.12230","article-title":"The structure of the human vaginal stratum corneum and its role in immune defense","volume":"71","author":"Anderson","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"2026010506140289700_ref13","doi-asserted-by":"publisher","first-page":"114543","DOI":"10.1016\/j.addr.2022.114543","article-title":"In vitro and ex vivo models for evaluating vaginal drug delivery systems","volume":"191","author":"Shapiro","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"2026010506140289700_ref14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/IJGM.S43192","article-title":"Barriers to effective treatment of vaginal atrophy with local estrogen therapy","volume":"6","author":"Reiter","year":"2013","journal-title":"Int J Gen Med"},{"issue":"2","key":"2026010506140289700_ref15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/sm2.17","article-title":"Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women","volume":"1","author":"Goldstein","year":"2013","journal-title":"Sex Med"},{"key":"2026010506140289700_ref16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.maturitas.2023.03.007","article-title":"Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale","volume":"172","author":"Palacios","year":"2023","journal-title":"Maturitas."},{"issue":"2","key":"2026010506140289700_ref17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/13697137.2017.1421921","article-title":"Nieto C; as the writing group of the GENISSE study. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study","volume":"21","author":"Moral","year":"2018","journal-title":"Climacteric."},{"issue":"1","key":"2026010506140289700_ref18","first-page":"3","article-title":"ISSVD classification of vulvar dermatoses: pathologic subsets and their clinical correlates","volume":"52","author":"Lynch","year":"2006","journal-title":"J Reprod Med"},{"key":"2026010506140289700_ref19","first-page":"1","author":"AEPCC-Gu\u00eda","year":"2016"},{"key":"2026010506140289700_ref20","doi-asserted-by":"publisher","author":"Day","DOI":"10.59153\/adm.ls.001"},{"issue":"4","key":"2026010506140289700_ref21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4274\/tjod.galenos.2019.23356","article-title":"Platelet-rich plasma administration to the lower anterior vaginal wall to improve female sexuality satisfaction","volume":"16","author":"Sukgen","year":"2019","journal-title":"Turk J Obstet Gynecol"},{"issue":"9","key":"2026010506140289700_ref22","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1089\/jwh.2023.0144","article-title":"Comparable efficacy of submucosal platelet-rich plasma and combined platelet-rich plasma noncrosslinked hyaluronic acid injections in vulvovaginal atrophy: a cancer survivorship issue","volume":"32","author":"Omar","year":"2023","journal-title":"J Women's Health (Larchmt)"},{"key":"2026010506140289700_ref23","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1111\/jocd.14873","article-title":"Clinical evaluation of autologous platelet rich plasma injection in postmenopausal vulvovaginal atrophy: a pilot study","volume":"21","author":"Saleh","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"8","key":"2026010506140289700_ref24","doi-asserted-by":"publisher","first-page":"e68004","DOI":"10.7759\/cureus.68004","article-title":"Platelet-rich plasma in urogynecology: a case series","volume":"16","author":"Ng","year":"2024","journal-title":"Cureus."},{"issue":"18","key":"2026010506140289700_ref25","doi-asserted-by":"publisher","first-page":"e00062","DOI":"10.1016\/j.crwh.2018.e00062","article-title":"Platelet-rich plasma (PRP) for the treatment of vulvar lichen sclerosus in a premenopausal woman: a case report","volume":"18","author":"Franic","year":"2018","journal-title":"Case Rep Womens Health"},{"key":"2026010506140289700_ref26","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/GME.0000000000001122","article-title":"Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study","volume":"25","author":"Hersant","year":"2018","journal-title":"Menopause."},{"issue":"6","key":"2026010506140289700_ref27","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00403-023-02529-1","article-title":"Mid-term symptomatic relief after platelet-rich plasma infiltration in vulvar lichen sclerosus","volume":"315","author":"Medina Garrido","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"2026010506140289700_ref28","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1080\/09546634.2020.1854650","article-title":"Platelet rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender related differences in symptoms and therapeutic response to PRP?","volume":"33","author":"Tedesco","year":"2022","journal-title":"J Dermatol Treat"},{"issue":"6","key":"2026010506140289700_ref29","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s00404-024-07424-2","article-title":"Is there a role for platelet rich plasma injection in vulvar lichen sclerosus? A self-controlled pilot study","volume":"309","author":"Boero","year":"2024","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"2026010506140289700_ref30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/09546634.2019.1685644","article-title":"Usefulness of video thermography in the evaluation of platelet-rich plasma effectiveness in vulvar lichen sclerosus: preliminary study","volume":"32","author":"Tedesco","year":"2021","journal-title":"J Dermatol Treatment"},{"issue":"252","key":"2026010506140289700_ref31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.31729\/jnma.7622","article-title":"Plasma cell vulvitis treated with platelet-rich plasma: a case report","volume":"60","author":"Oli","year":"2022","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"1","key":"2026010506140289700_ref32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaad.2016.07.037","article-title":"Intradermal injection of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus","volume":"76","author":"Goldstein","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2026010506140289700_ref33","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jaad.2018.12.060","article-title":"A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus","volume":"80","author":"Goldstein","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2026010506140289700_ref34","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/LGT.0000000000000330","article-title":"Zoon Vulvitis treated successfully with platelet-rich plasma: first case reported","volume":"21","author":"Jaimes Suarez","year":"2017","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"2026010506140289700_ref35","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/LGT.0000000000000121","article-title":"Abstracts","volume":"19","author":"ISSVD","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"2026010506140289700_ref36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4172\/2167-0420.1000169","article-title":"A pilot study of the effect of localized injections of autologous platelet rich plasma (PRP) for the treatment of female sexual dysfunction","volume":"03","author":"Runels","year":"2014","journal-title":"J Women\u2019s Health Care"},{"issue":"4","key":"2026010506140289700_ref37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.15406\/ogij.2022.13.00653","article-title":"Platelet rich plasma, in the treatment of sexual dysfunction afther pelvic radiotherapy for cancer","volume":"13","author":"Isaac","year":"2022","journal-title":"Obstet Gynecol Int J"},{"key":"2026010506140289700_ref38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4172\/2167-0420.1000395","article-title":"O-shot: platelets rich plasma in intimate female treatment","volume":"06","author":"Neto","year":"2017","journal-title":"J Women's Health Care"},{"issue":"3","key":"2026010506140289700_ref39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/074880681102800309","article-title":"Vaginal fractional CO2 laser: a minimally invasive option for vaginal rejuvenation","volume":"28","author":"Gaspar","year":"2011","journal-title":"Am J Cosmetic Surg"},{"issue":"2","key":"2026010506140289700_ref40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijwd.2019.02.003","article-title":"Vaginal rejuvenation: from scalpel to wands","volume":"5","author":"Desai","year":"2019","journal-title":"Int J Women's Dermatol"},{"issue":"4","key":"2026010506140289700_ref41","first-page":"272","article-title":"Platelet-rich plasma and genital rejuvenation","volume":"17","author":"Cohen","year":"2019","journal-title":"Skinmed."},{"issue":"9","key":"2026010506140289700_ref44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/DSS.0000000000000697","article-title":"Emerging trends in nonsurgical female genital rejuvenation","volume":"42","author":"Vanaman","year":"2016","journal-title":"Dermatol Surg"},{"issue":"9","key":"2026010506140289700_ref45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2147\/IJWH.S99700","article-title":"Vaginal rejuvenation: current perspectives","volume":"9","author":"Barbara","year":"2017","journal-title":"Int J Women's Health"},{"issue":"1","key":"2026010506140289700_ref42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/17474086.2021.1860002","article-title":"Evidence-based indications of platelet-rich plasma therapy","volume":"14","author":"Gupta","year":"2020","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"2026010506140289700_ref43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/15533506211014848","article-title":"The emerging role on the use of platelet-rich plasma products in the management of urogynaecological disorders","volume":"29","author":"Prodromidou","year":"2022","journal-title":"Surg Innov"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/23\/1\/qdaf307\/65044357\/qdaf307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/23\/1\/qdaf307\/65044357\/qdaf307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:14:10Z","timestamp":1767611650000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/doi\/10.1093\/jsxmed\/qdaf307\/8307091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdaf307","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,10,31]]},"article-number":"qdaf307"}}